App-based assessment of patient-reported outcomes in the Molecular Tumor Board in the Center for Personalized Medicine-(TRACE).
Lorenz DörnerLucia GrosseFelix StangeHanni HilleSylvia KurzHannes BeckerSebastian VolkmerMelina HipplerDavid RiegerPaula BombachJohannes RiegerLina WeinertLaura SvenssonCarolin AndersSila CekinFrank PaulsenÖznur ÖnerKristina RuhmHolly Sundberg MalekYonne MöllerMarcos TatagibaMarkus WallwienerNils EckertPascal EscherNico PfeiferAndrea ForschnerArmin BauerDaniel ZipsMichael BitzerNisar MalekCihan GaniGhazaleh TabatabaiMirjam RenovanzPublished in: Neuro-oncology practice (2024)
This pilot study proved the feasibility and acceptance of the app. We will therefore expand its application during biomarker-guided therapies to enable systematic PRO assessments.